Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Mankind Pharma Ltd.
₹2,045
Invest in MANKIND with up to 3.57x margin.
Trade with MTF₹2012.30
₹2050.00
₹2014.90
₹2716.50
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 2,632.68 | 2,608.78 | 2,541.36 | 2,126.59 | 2,396.57 |
| Operating Expense | 1,854.43 | 1,915.59 | 1,868.29 | 1,633.85 | 1,655.64 |
| Operating Profit | 778.25 | 693.19 | 673.07 | 476.92 | 740.93 |
| Depreciation | 107.69 | 99.03 | 96.93 | 105.24 | 87.03 |
| Interest | 138.37 | 147.20 | 146.70 | 162.25 | 199.47 |
| Tax | 55.82 | 65.73 | 80.90 | 46.29 | 107.87 |
| Net Profit | 449.47 | 458.90 | 412.76 | 382.46 | 416.38 |
Research Type
Equity , Long Term
Buy Range
₹2,309 - ₹0
Target Price
₹2,530
Stop Loss
-
Target Date
10 Nov 26
Potential Returns
9.57 %
₹2045.00
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 74.9 | 72.7 | 72.7 | 72.7 | 72.7 | 72.7 |
| FII | 12.4 | 13.3 | 12.9 | 13.1 | 12.8 | 11.3 |
| DII | 9.9 | 11.1 | 11.5 | 11.5 | 11.9 | 13.3 |
| Public | 2.9 | 2.9 | 2.9 | 2.8 | 2.6 | 2.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.18 L | 2.13 L | 55.23% |
| Week | 2.19 L | 3.37 L | 64.82% |
| 1 Month | 2.12 L | 3.83 L | 55.28% |
| 6 Month | 2.87 L | 4.46 L | 64.23% |
Benjamin Graham Value Screen
Expensive Performers (DVM)
PEG lower than Industry PEG
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 08 Aug, 2025 | 1 | INTERIM | 08 Aug, 2025 | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹696.90 | ₹1,431.80 | ₹162 | ₹1,803 | ₹1,014.60 |
| % Change | 2.20% | -0.42% | 0.92% | -1.03% | -0.43% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹8,850.08 | ₹8,871.37 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹869.92 | ₹-163.61 | ₹847.18 | ₹843.32 |
| PE TTM | 80.70 | 31.30 | -131.70 | 35.10 | 65.10 |
| 1 Year Return | 22.17 | 44.17 | -22.44 | 18.09 | 95.04 |
| ROCE | 26.88 | 20.80 | 6.40 | 11.43 | 11.82 |
Alkem Laboratories Ltd.
₹ 5487.00
+1.76%
Biocon Ltd.
₹ 388.00
+1.05%
Divi's Laboratories Ltd.
₹ 6258.50
-0.52%
Ajanta Pharma Ltd.
₹ 2975.00
+1.21%
Zydus Lifesciences Ltd.
₹ 905.30
-
Glenmark Pharmaceuticals Ltd.
₹ 2033.00
-0.50%
Wockhardt Ltd.
₹ 1370.00
-0.84%
Aurobindo Pharma Ltd.
₹ 1148.70
-0.87%
Sun Pharmaceutical Industries Ltd.
₹ 1732.00
+0.44%
Ipca Laboratories Ltd.
₹ 1469.70
+1.37%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2051.00
+2.53%
AstraZeneca Pharma India Ltd.
₹ 8807.00
-0.93%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2635.30
+1.48%
Pfizer Ltd.
₹ 5066.60
+2.74%
Abbott India Ltd.
₹ 26425.00
+0.49%
Torrent Pharmaceuticals Ltd.
₹ 4318.50
+1.81%
Lupin Ltd.
₹ 2241.00
+0.97%
Dr. Reddy's Laboratories Ltd.
₹ 1305.10
+1.93%
Cipla Ltd.
₹ 1327.00
-1.05%
By signing up I certify terms, conditions & privacy policy